Area of research
Oncology · Economics and Econometrics
Research interest
Research interests include Cancer survivorship and care, Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer, and Statistical Methods in Clinical Trials.
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
Minimally important differences for interpreting the EORTC QLQ‐C30 in patients with advanced colorectal cancer treated with chemotherapy
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review
Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials